I read this, went "good" and went back to mowing the grass. Now we have a half reasonable answer to the Melbourne slowdown and a bit of a road map for 008 that sits within the overall FDA plan. This is fine, really.
Now I want the FDA Phase III trial approval announcement. That'll make us all smile (or at least a little less grumpy)....
Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-35
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $71.73M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 19.5¢ | $323.1K | 1.612M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 324 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 52928 | 5 |
View Market Depth
| Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |